These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1418102)

  • 1. Comparative hypolipidemic effects of lovastatin and simvastatin in patients with heterozygous familial hypercholesterolemia.
    Illingworth DR; Bacon S; Pappu AS; Sexton GJ
    Atherosclerosis; 1992 Sep; 96(1):53-64. PubMed ID: 1418102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of simvastatin on plasma lipoproteins and cholesterol homeostasis in patients with heterozygous familial hypercholesterolaemia.
    Hagemenas FC; Pappu AS; Illingworth DR
    Eur J Clin Invest; 1990 Apr; 20(2):150-7. PubMed ID: 2112479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of simvastatin on adrenal corticosteroid production and urinary mevalonate during adrenocorticotropin stimulation in patients with heterozygous familial hypercholesterolemia.
    Prihoda JS; Pappu AS; Smith FE; Illingworth DR
    J Clin Endocrinol Metab; 1991 Mar; 72(3):567-74. PubMed ID: 1847705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the efficacy of simvastatin and standard fibrate therapy in the treatment of primary hypercholesterolemia and combined hyperlipidemia.
    Bruckert E; De Gennes JL; Malbecq W; Baigts F
    Clin Cardiol; 1995 Nov; 18(11):621-9. PubMed ID: 8590530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Simvastatin in the treatment of familial hypercholesterolemia].
    Ceska R; Sobra J; Procházková R; Kvasilová M
    Cas Lek Cesk; 1995 May; 134(10):310-3. PubMed ID: 7788650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of long-term treatment with simvastatin on plasma lipids and lipoproteins in patients with primary hypercholesterolemia.
    Thiery J; Creutzfeldt C; Creutzfeldt W; Walli AK; Seidel D
    Klin Wochenschr; 1990 Aug; 68(16):814-22. PubMed ID: 2214604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS; Bacon SP; Illingworth DR
    J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrasting effects of lovastatin and cholestyramine on low-density lipoprotein cholesterol and 24-hour urinary mevalonate excretion in patients with heterozygous familial hypercholesterolemia.
    Pappu AS; Illingworth DR
    J Lab Clin Med; 1989 Nov; 114(5):554-62. PubMed ID: 2809398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of lovastatin on concentrations and composition of lipoprotein subfractions.
    Nozaki S; Vega GL; Haddox RJ; Dolan ET; Grundy SM
    Atherosclerosis; 1990 Oct; 84(2-3):101-10. PubMed ID: 2282090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction in plasma low-density lipoprotein cholesterol and urinary mevalonic acid by lovastatin in patients with heterozygous familial hypercholesterolemia.
    Pappu AS; Illingworth DR; Bacon S
    Metabolism; 1989 Jun; 38(6):542-9. PubMed ID: 2725293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of lovastatin and simvastatin on the diurnal periodicity of plasma mevalonate concentrations in patients with heterozygous familial hypercholesterolemia.
    Pappu AS; Illingworth DR
    Atherosclerosis; 2002 Nov; 165(1):137-44. PubMed ID: 12208479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose effect of simvastatin (MK-733) on serum lipids, lipoproteins, and apolipoproteins in patients with hypercholesterolemia.
    Saku K; Sasaki J; Arakawa K
    Clin Ther; 1989; 11(2):247-57. PubMed ID: 2736571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter comparison of micronized fenofibrate and simvastatin in patients with primary type IIA or IIB hyperlipoproteinemia.
    Steinmetz A; Schwartz T; Hehnke U; Kaffarnik H
    J Cardiovasc Pharmacol; 1996 Apr; 27(4):563-70. PubMed ID: 8847874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemia.
    Naoumova RP; Marais AD; Mountney J; Firth JC; Rendell NB; Taylor GW; Thompson GR
    Atherosclerosis; 1996 Jan; 119(2):203-13. PubMed ID: 8808497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One year experience in the treatment of familial hypercholesterolaemia with simvastatin.
    Quiney J; Watts GF; Kerr-Muir M; Slavin B; Lewis B
    Postgrad Med J; 1992 Jul; 68(801):575-80. PubMed ID: 1437957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of apolipoprotein E phenotype on the response to lovastatin therapy in patients with heterozygous familial hypercholesterolemia.
    O'Malley JP; Illingworth DR
    Metabolism; 1990 Feb; 39(2):150-4. PubMed ID: 2299987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of simvastatin and ciprofibrate alone and in combination on lipid profile, plasma fibrinogen and low density lipoprotein particle structure and distribution in patients with familial combined hyperlipidaemia and coronary artery disease.
    Kontopoulos AG; Athyros VG; Papageorgiou AA; Hatzikonstandinou HA; Mayroudi MC; Boudoulas H
    Coron Artery Dis; 1996 Nov; 7(11):843-50. PubMed ID: 8993943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of simvastatin on high density lipoprotein subfractions and apolipoproteins in type IIa hypercholesterolemia.
    Crook D; Bruce R; Worthington M; Mulcahy D; Patterson D; Wynn V
    Cardiovasc Drugs Ther; 1992 Dec; 6(6):633-9. PubMed ID: 1292582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of lovastatin alone and in combination with cholestyramine on serum lipids and apolipoproteins in heterozygotes for familial hypercholesterolemia.
    Leren TP; Hjermann I; Berg K; Leren P; Foss OP; Viksmoen L
    Atherosclerosis; 1988 Oct; 73(2-3):135-41. PubMed ID: 3056429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of lovastatin plus gemfibrozil on plasma lipids and lipoproteins in patients with heterozygous familial hypercholesterolemia.
    Illingworth DR; Bacon S
    Circulation; 1989 Mar; 79(3):590-6. PubMed ID: 2645064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.